Download PDF
Semin Liver Dis 2016; 36(03): 257-273
DOI: 10.1055/s-0036-1584318
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Current Concepts and Diagnosis of IgG4-Related Pancreatitis (Type 1 AIP)

Shigeyuki Kawa
1   Center for Health, Safety, and Environmental Management, Shinshu University, Matsumoto, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
28 July 2016 (online)

    Permissions and Reprints

Abstract

Although now considered to be a member of the systemic entity of immunoglobulin G4- (IgG4-) related disease, IgG4-related pancreatitis is generally referred to as type 1 autoimmune pancreatitis (AIP). Type 1 AIP was established based on a pathological background of lymphoplasmacytic sclerosing pancreatitis, high serum IgG4 concentration, and abundant IgG4-bearing plasma cell infiltration. The characteristic clinical features of type 1 AIP, such as elderly male preponderance, obstructive jaundice, and mass-forming lesions in the pancreas, often mimic those of pancreatic cancer. However, because AIP responds favorably to corticosteroid treatment, careful differentiation from pancreatic cancer is required. An AIP diagnosis is currently based on the 2011 International Consensus Diagnostic Criteria for AIP, which are based on high sensitivity, selectivity, and accuracy. Over the long term, AIP can progress to a chronic condition, with pancreatic stone formation and atrophy resembling that of chronic pancreatitis. Although AIP has been linked to the complication of malignancies, it remains controversial whether an association exists between the disease and tumor formation.

Keywords

autoimmune pancreatitis - immunoglobulin G4-related disease - immunoglobulin G4 - immunoglobulin G4-related pancreatitis
 

  • References

  • 1 Stone JH, Khosroshahi A, Deshpande V , et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012; 64 (10) 3061-3067
    CrossrefPubMedGoogle Scholar
  • 2 Kawa S, Hamano H, Kiyosawa K. Autoimmune pancreatitis and IgG4-related disease. In: Rose N, MacKay I, eds. The autoimmune diseases. 5th ed. St. Louis, MO: Academic Press; 2013: 935-949
    Google Scholar
  • 3 Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366 (6) 539-551
    CrossrefPubMedGoogle Scholar
  • 4 Sugumar A, Klöppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol 2009; 104 (9) 2308-2310 , quiz 2311
    CrossrefPubMedGoogle Scholar
  • 5 Okazaki K, Tomiyama T, Mitsuyama T, Sumimoto K, Uchida K. Diagnosis and classification of autoimmune pancreatitis. Autoimmun Rev 2014; 13 (4–5) 451-458
    CrossrefPubMedGoogle Scholar
  • 6 Hart PA, Zen Y, Chari ST. Recent advances in autoimmune pancreatitis. Gastroenterology 2015; 149 (1) 39-51
    CrossrefPubMedGoogle Scholar
  • 7 Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease?. Am J Dig Dis 1961; 6: 688-698
    CrossrefPubMedGoogle Scholar
  • 8 Waldram R, Kopelman H, Tsantoulas D, Williams R. Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet 1975; 1 (7906) 550-552
    PubMedGoogle Scholar
  • 9 Nakano S, Takeda I, Kitamura K, Watahiki H, Iimura Y, Takenaka M. Vanishing tumor of the abdomen in patient with Sjoegren's syndrome. Dig Dis 1978; 23: 75-79
    PubMedGoogle Scholar
  • 10 Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22 (4) 387-395
    CrossrefPubMedGoogle Scholar
  • 11 Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med 1967; 66 (5) 884-892
    CrossrefPubMedGoogle Scholar
  • 12 Toki F, Kozu T, Oi I, Nakasato T, Suzuki M, Hanyu F. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP-A report of four cases. Endoscopy 1992; 24: 640
    PubMedGoogle Scholar
  • 13 Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40 (7) 1561-1568
    CrossrefPubMedGoogle Scholar
  • 14 Hamano H, Kawa S, Horiuchi A , et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344 (10) 732-738
    Google Scholar
  • 15 Hamano H, Kawa S, Ochi Y , et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359 (9315) 1403-1404
    CrossrefPubMedGoogle Scholar
  • 16 Pearson RK, Longnecker DS, Chari ST , et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist?. Pancreas 2003; 27 (1) 1-13
    CrossrefPubMedGoogle Scholar
  • 17 Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003; 27 (8) 1119-1127
    CrossrefPubMedGoogle Scholar
  • 18 Zamboni G, Lüttges J, Capelli P , et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004; 445 (6) 552-563
    CrossrefPubMedGoogle Scholar
  • 19 Nishimori I, Tamakoshi A, Otsuki M ; Research Committee on Intractable Diseases of the Pancreas, Ministry of Health, Labour, and Welfare of Japan. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007; 42 (Suppl. 18) 6-8
    CrossrefPubMedGoogle Scholar
  • 20 Kanno A, Nishimori I, Masamune A , et al; Research Committee on Intractable Diseases of Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas 2012; 41 (6) 835-839
    CrossrefPubMedGoogle Scholar
  • 21 Kanno A, Masamune A, Okazaki K , et al; Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas 2015; 44 (4) 535-539
    CrossrefPubMedGoogle Scholar
  • 22 Hart PA, Kamisawa T, Brugge WR , et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62 (12) 1771-1776
    CrossrefPubMedGoogle Scholar
  • 23 Tanaka S, Kobayashi T, Nakanishi K , et al. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000; 356 (9233) 910-911
    CrossrefPubMedGoogle Scholar
  • 24 Nishimori I, Tamakoshi A, Kawa S , et al; Research Committee on Intractable Pancreatic Diseases, the Ministry of Health and Welfare of Japan. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas 2006; 32 (3) 244-248
    CrossrefPubMedGoogle Scholar
  • 25 Ko SB, Mizuno N, Yatabe Y , et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology 2010; 138 (5) 1988-1996
    CrossrefPubMedGoogle Scholar
  • 26 Kamisawa T, Funata N, Hayashi Y , et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52 (5) 683-687
    CrossrefPubMedGoogle Scholar
  • 27 Hirano K, Kawabe T, Komatsu Y , et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J 2006; 36 (1) 58-61
    CrossrefPubMedGoogle Scholar
  • 28 Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 2006; 32 (2) 229
    CrossrefPubMedGoogle Scholar
  • 29 Matsubayashi H, Kishida Y, Yoshida Y , et al. Autoimmune pancreatitis with colonic stenosis: an unusual complication and atypical pancreatographic finding. BMC Gastroenterol 2014; 14: 173
    CrossrefPubMedGoogle Scholar
  • 30 Muraki T, Hamano H, Ochi Y , et al. Autoimmune pancreatitis and complement activation system. Pancreas 2006; 32 (1) 16-21
    CrossrefPubMedGoogle Scholar
  • 31 Saeki T, Saito A, Yamazaki H , et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol 2007; 11 (2) 168-173
    CrossrefPubMedGoogle Scholar
  • 32 Taguchi M, Kihara Y, Nagashio Y, Yamamoto M, Otsuki M, Harada M. Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J Gastroenterol 2009; 44 (11) 1133-1139
    CrossrefPubMedGoogle Scholar
  • 33 Ito T, Nakano I, Koyanagi S , et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997; 42 (7) 1458-1468
    CrossrefPubMedGoogle Scholar
  • 34 Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004; 60 (6) 927-936
    CrossrefPubMedGoogle Scholar
  • 35 Naitoh I, Nakazawa T, Ohara H , et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol 2009; 44 (11) 1147-1155
    CrossrefPubMedGoogle Scholar
  • 36 Irie H, Honda H, Baba S , et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998; 170 (5) 1323-1327
    CrossrefPubMedGoogle Scholar
  • 37 Sahani DV, Kalva SP, Farrell J , et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233 (2) 345-352
    CrossrefPubMedGoogle Scholar
  • 38 Oki H, Hayashida Y, Oki H , et al. DWI findings of autoimmune pancreatitis: comparison between symptomatic and asymptomatic patients. J Magn Reson Imaging 2015; 41 (1) 125-131
    CrossrefPubMedGoogle Scholar
  • 39 Wakabayashi T, Kawaura Y, Satomura Y , et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98 (12) 2679-2687
    CrossrefPubMedGoogle Scholar
  • 40 Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002; 55 (4) 494-499
    CrossrefPubMedGoogle Scholar
  • 41 Kanno A, Masamune A, Shimosegawa T. Endoscopic approaches for the diagnosis of autoimmune pancreatitis. Dig Endosc 2015; 27 (2) 250-258
    CrossrefPubMedGoogle Scholar
  • 42 Nakazawa T, Ohara H, Sano H , et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc 2007; 65 (1) 99-108
    CrossrefPubMedGoogle Scholar
  • 43 Nishino T, Oyama H, Hashimoto E , et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007; 42 (7) 550-559
    CrossrefPubMedGoogle Scholar
  • 44 Nakamoto Y, Saga T, Ishimori T , et al. FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med 2000; 27 (12) 1835-1838
    CrossrefPubMedGoogle Scholar
  • 45 Ozaki Y, Oguchi K, Hamano H , et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 2008; 43 (2) 144-151
    CrossrefPubMedGoogle Scholar
  • 46 Lee TY, Kim MH, Park H , et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 2009; 193 (2) 343-348
    CrossrefPubMedGoogle Scholar
  • 47 Shigekawa M, Yamao K, Sawaki A , et al. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?. J Hepatobiliary Pancreat Sci 2010; 17 (3) 269-274
    CrossrefPubMedGoogle Scholar
  • 48 Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol 2007; 42 (Suppl. 18) 9-14
    CrossrefPubMedGoogle Scholar
  • 49 Okazaki K, Kawa S, Kamisawa T , et al; Research Committee of Intractable Diseases of the Pancreas. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006; 41 (7) 626-631
    CrossrefPubMedGoogle Scholar
  • 50 Shimosegawa T, Chari ST, Frulloni L , et al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40 (3) 352-358
    CrossrefPubMedGoogle Scholar
  • 51 Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41 (12) 1197-1205
    PubMedGoogle Scholar
  • 52 Matsubayashi H, Sawai H, Kimura H , et al. Characteristics of autoimmune pancreatitis based on serum IgG4 level. Dig Liver Dis 2011; 43 (9) 731-735
    CrossrefPubMedGoogle Scholar
  • 53 Chari ST, Smyrk TC, Levy MJ , et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4 (8) 1010-1016 , quiz 934
    CrossrefPubMedGoogle Scholar
  • 54 Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006; 12 (16) 2487-2496
    CrossrefPubMedGoogle Scholar
  • 55 Otsuki M, Chung JB, Okazaki K , et al; Research Committee of Intractable Pancreatic Diseases provided by the Ministry of Health, Labour and Welfare of Japan and the Korean Society of Pancreatobiliary Diseases. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008; 43 (6) 403-408
    CrossrefPubMedGoogle Scholar
  • 56 Shimosegawa T ; Working Group Members of the Japan Pancreas Society; Research Committee for Intractable Pancreatic Disease by the Ministry of Labor, Health and Welfare of Japan. The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for Autoimmune Pancreatitis. Pancreas 2012; 41 (8) 1341-1342
    CrossrefPubMedGoogle Scholar
  • 57 Maruyama M, Watanabe T, Kanai K , et al. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis and Its Japanese Amendment have improved diagnostic ability over existing criteria. Gastroenterol Res Pract 2013; 2013 (13) 456965
    PubMedGoogle Scholar
  • 58 Sumimoto K, Uchida K, Mitsuyama T , et al. A proposal of a diagnostic algorithm with validation of International Consensus Diagnostic Criteria for autoimmune pancreatitis in a Japanese cohort. Pancreatology 2013; 13 (3) 230-237
    CrossrefPubMedGoogle Scholar
  • 59 Naitoh I, Nakazawa T, Hayashi K , et al. Clinical evaluation of international consensus diagnostic criteria for type 1 autoimmune pancreatitis in comparison with Japanese diagnostic criteria 2011. Pancreas 2013; 42 (8) 1238-1244
    CrossrefPubMedGoogle Scholar
  • 60 Tabata T, Kamisawa T, Kuruma S , et al. Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. Int J Rheumatol 2013; 2013 (13) 465428
    PubMedGoogle Scholar
  • 61 Ikeura T, Detlefsen S, Zamboni G , et al. Retrospective comparison between preoperative diagnosis by International Consensus Diagnostic Criteria and histological diagnosis in patients with focal autoimmune pancreatitis who underwent surgery with suspicion of cancer. Pancreas 2014; 43 (5) 698-703
    CrossrefPubMedGoogle Scholar
  • 62 Abraham SC, Wilentz RE, Yeo CJ , et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’?. Am J Surg Pathol 2003; 27 (1) 110-120
    CrossrefPubMedGoogle Scholar
  • 63 Weber SM, Cubukcu-Dimopulo O, Palesty JA , et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7 (1) 129-137 , discussion 137–139
    CrossrefPubMedGoogle Scholar
  • 64 Kawa S, Okazaki K, Kamisawa T , et al; Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 2014; 49 (5) 765-784
    CrossrefPubMedGoogle Scholar
  • 65 Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol 2009; 44 (6) 503-517
    CrossrefPubMedGoogle Scholar
  • 66 Ghazale A, Chari ST, Smyrk TC , et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102 (8) 1646-1653
    CrossrefPubMedGoogle Scholar
  • 67 van Heerde MJ, Buijs J, Hansen BE , et al. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma. Dig Dis Sci 2014; 59 (6) 1322-1329
    PubMedGoogle Scholar
  • 68 Ichikawa T, Sou H, Araki T , et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 2001; 221 (1) 107-116
    CrossrefPubMedGoogle Scholar
  • 69 Takahashi N, Fletcher JG, Fidler JL, Hough DM, Kawashima A, Chari ST. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol 2008; 190 (2) 280-286
    CrossrefPubMedGoogle Scholar
  • 70 Chang WI, Kim BJ, Lee JK , et al. The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis: comparison with chronic pancreatitis and pancreatic cancer. Pancreas 2009; 38 (4) 401-408
    CrossrefPubMedGoogle Scholar
  • 71 Nishino T, Oyama H, Toki F, Shiratori K. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol 2010; 45 (9) 988-996
    CrossrefPubMedGoogle Scholar
  • 72 Kamisawa T, Tu Y, Egawa N , et al. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?. Abdom Imaging 2009; 34 (3) 381-384
    CrossrefPubMedGoogle Scholar
  • 73 Matsubayashi H, Furukawa H, Maeda A , et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 2009; 9 (5) 694-699
    CrossrefPubMedGoogle Scholar
  • 74 Bang SJ, Kim MH, Kim H , et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis?. Pancreas 2008; 36 (1) 84-89
    CrossrefPubMedGoogle Scholar
  • 75 Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20 (1) 23-28
    CrossrefPubMedGoogle Scholar
  • 76 Uehara T, Hamano H, Kawa S , et al. Comparison of histopathological features of pancreatic carcinoma and type 1 autoimmune pancreatitis. Pathol Int 2014; 64 (2) 51-57
    CrossrefPubMedGoogle Scholar
  • 77 Witkiewicz AK, Kennedy EP, Kennyon L, Yeo CJ, Hruban RH. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol 2008; 39 (10) 1548-1551
    CrossrefPubMedGoogle Scholar
  • 78 Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreatology 2010; 10 (6) 664-672
    CrossrefPubMedGoogle Scholar
  • 79 Kawa S, Okazaki K, Notohara K, Watanabe M, Shimosegawa T ; Study Group for Pancreatitis Complicated with Inflammatory Bowel Disease organized by The Research Committee for Intractable Pancreatic Disease (Chairman: Tooru Shimosegawa) and the Research Committee for Intractable Inflammatory Bowel Disease (Chairman: Mamoru Watanabe), both of which are supported by the Ministry of Health, Labour, and Welfare of Japan. Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis. J Gastroenterol 2015; 50 (7) 805-815
    CrossrefPubMedGoogle Scholar
  • 80 Zhu J, Wang L, Chu Y , et al. A new descriptor for computer-aided diagnosis of EUS imaging to distinguish autoimmune pancreatitis from chronic pancreatitis. Gastrointest Endosc 2015; 82 (5) 831-836.e1
    CrossrefPubMedGoogle Scholar
  • 81 Takayama M, Hamano H, Ochi Y , et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004; 99 (5) 932-937
    CrossrefPubMedGoogle Scholar
  • 82 Maruyama M, Arakura N, Ozaki Y , et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol 2012; 47 (5) 553-560
    CrossrefPubMedGoogle Scholar
  • 83 Masuda A, Shiomi H, Matsuda T , et al. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis. Pancreatology 2014; 14 (5) 361-365
    CrossrefPubMedGoogle Scholar
  • 84 Maruyama M, Arakura N, Ozaki Y , et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol 2013; 2013 (13) 272595
    PubMedGoogle Scholar
  • 85 Ito T, Kawabe K, Arita Y , et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007; 34 (2) 254-259
    CrossrefPubMedGoogle Scholar
  • 86 Frulloni L, Scattolini C, Katsotourchi AM , et al. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment. Pancreatology 2010; 10 (2–3) 129-133
    CrossrefPubMedGoogle Scholar
  • 87 Song MH, Kim MH, Lee SK , et al. Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis. Pancreas 2005; 30 (1) 83-86
    PubMedGoogle Scholar
  • 88 Kubota K, Watanabe S, Uchiyama T , et al. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol 2011; 46 (6) 834-842
    CrossrefPubMedGoogle Scholar
  • 89 Hirano K, Tada M, Isayama H , et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007; 56 (12) 1719-1724
    CrossrefPubMedGoogle Scholar
  • 90 Kim HM, Chung MJ, Chung JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas 2010; 39 (5) 555-560
    CrossrefPubMedGoogle Scholar
  • 91 Kamisawa T, Shimosegawa T, Okazaki K , et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58 (11) 1504-1507
    CrossrefPubMedGoogle Scholar
  • 92 Kamisawa T, Okazaki K, Kawa S , et al; Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol 2014; 49 (6) 961-970
    CrossrefPubMedGoogle Scholar
  • 93 Kawa S, Hamano H, Ozaki Y , et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol 2009; 7 (11, Suppl) S18-S22
    CrossrefPubMedGoogle Scholar
  • 94 Kubota K, Iida H, Fujisawa T , et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007; 66 (6) 1142-1151
    CrossrefPubMedGoogle Scholar
  • 95 Park H, Kim MH, Oh HB , et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134 (2) 440-446
    CrossrefPubMedGoogle Scholar
  • 96 Umemura T, Ota M, Hamano H , et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008; 103 (3) 588-594
    CrossrefPubMedGoogle Scholar
  • 97 Takuma K, Kamisawa T, Tabata T, Inaba Y, Egawa N, Igarashi Y. Short-term and long-term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2011; 23 (2) 146-152
    CrossrefPubMedGoogle Scholar
  • 98 Maire F, Le Baleur Y, Rebours V , et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011; 106 (1) 151-156
    CrossrefPubMedGoogle Scholar
  • 99 Uemura N, Okamoto S, Yamamoto S , et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345 (11) 784-789
    CrossrefPubMedGoogle Scholar
  • 100 Kiyosawa K, Umemura T, Ichijo T , et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004; 127 (5) (Suppl. 01) S17-S26
    CrossrefPubMedGoogle Scholar
  • 101 Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6 (10) 715-727
    CrossrefPubMedGoogle Scholar
  • 102 Henderson BE, Bogdanoff E, Gerkins VR, SooHoo J, Arthur M. Evaluation of cancer risk factors in a retirement community. Cancer Res 1974; 34 (5) 1045-1048
    PubMedGoogle Scholar
  • 103 Yamamoto M, Takahashi H, Tabeya T , et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol 2012; 22 (3) 414-418
    CrossrefPubMedGoogle Scholar
  • 104 Shiokawa M, Kodama Y, Yoshimura K , et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 2013; 108 (4) 610-617
    CrossrefPubMedGoogle Scholar
  • 105 Hirano K, Tada M, Sasahira N , et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med 2014; 53 (3) 171-176
    CrossrefPubMedGoogle Scholar
  • 106 Motosugi U, Ichikawa T, Yamaguchi H , et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int 2009; 59 (10) 744-747
    CrossrefPubMedGoogle Scholar
  • 107 Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer?. Pancreas 2007; 35 (4) 376
    PubMedGoogle Scholar
  • 108 Inoue H, Miyatani H, Sawada Y, Yoshida Y. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 2006; 33 (2) 208-209
    CrossrefPubMedGoogle Scholar
  • 109 Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsushita M, Okazaki K. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med 2008; 47 (3) 151-155
    CrossrefPubMedGoogle Scholar
  • 110 Lowenfels AB, Maisonneuve P, Cavallini G , et al; International Pancreatitis Study Group. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328 (20) 1433-1437
    CrossrefPubMedGoogle Scholar
  • 111 Fujinaga Y, Kadoya M, Kawa S , et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 2010; 76 (2) 228-238
    CrossrefPubMedGoogle Scholar
  • 112 Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6 (1–2) 132-137
    CrossrefPubMedGoogle Scholar
  • 113 Yamamoto M, Takahashi H, Ohara M , et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006; 16 (6) 335-340
    CrossrefPubMedGoogle Scholar
  • 114 Masaki Y, Dong L, Kurose N , et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68 (8) 1310-1315
    CrossrefPubMedGoogle Scholar
  • 115 van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 2004; 141 (11) 896-897
    CrossrefPubMedGoogle Scholar
  • 116 Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006; 4: 23
    CrossrefPubMedGoogle Scholar
  • 117 Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 2012; 29 (4) 177-190
    CrossrefPubMedGoogle Scholar
  • 118 Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010; 37 (7) 1380-1385
    CrossrefPubMedGoogle Scholar
  • 119 Ohara H, Okazaki K, Tsubouchi H , et al; Research Committee of IgG4-related Diseases; Research Committee of Intractable Diseases of Liver and Biliary Tract; Ministry of Health, Labor and Welfare, Japan; Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 2012; 19 (5) 536-542
    CrossrefPubMedGoogle Scholar
  • 120 Kawano M, Saeki T, Nakashima H , et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 2011; 15 (5) 615-626
    CrossrefPubMedGoogle Scholar
  • 121 Hara N, Kawaguchi M, Takeda K, Zen Y. Retroperitoneal disorders associated with IgG4-related autoimmune pancreatitis. World J Gastroenterol 2014; 20 (44) 16550-16558
    CrossrefPubMedGoogle Scholar
  • 122 Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 2009; 56 (9) 1033-1041
    CrossrefPubMedGoogle Scholar
  • 123 Watanabe T, Maruyama M, Ito T , et al. Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol 2013; 42 (4) 325-330
    CrossrefPubMedGoogle Scholar
  • 124 Hart PA, Smyrk TC, Chari ST. IgG4-related prostatitis: a rare cause of steroid-responsive obstructive urinary symptoms. Int J Urol 2013; 20 (1) 132-134
    CrossrefPubMedGoogle Scholar
  • 125 Joshi D, Jager R, Hurel S , et al. Cerebral involvement in IgG4-related disease. Clin Med (Lond) 2015; 15 (2) 130-134
    CrossrefPubMedGoogle Scholar
  • 126 Kosakai A, Ito D, Yamada S, Ideta S, Ota Y, Suzuki N. A case of definite IgG4-related pachymeningitis. Neurology 2010; 75 (15) 1390-1392
    CrossrefPubMedGoogle Scholar
  • 127 Mori K, Yamada K, Konno T , et al. Pericardial Involvement in IgG4-related disease. Intern Med 2015; 54 (10) 1231-1235
    CrossrefPubMedGoogle Scholar
  • 128 Koizumi S, Kamisawa T, Kuruma S , et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases?. World J Gastroenterol 2013; 19 (35) 5769-5774
    CrossrefPubMedGoogle Scholar
  • 129 Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46 (2) 463-471
    CrossrefPubMedGoogle Scholar
  • 130 Zen Y, Kitagawa S, Minato H , et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36 (7) 710-717
    CrossrefPubMedGoogle Scholar
  • 131 Inoue D, Zen Y, Abo H , et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 2011; 261 (2) 625-633
    Google Scholar
  • 132 Ise M, Yasuda F, Suzaki R, Kurihara S, Konohana I. Skin lesions in a patient with IgG4-related disease. Clin Exp Dermatol 2014; 39 (6) 713-716
    CrossrefPubMedGoogle Scholar
  • 133 Nakamura A, Funatomi H, Katagiri A , et al. A case of autoimmune pancreatitis complicated with immune thrombocytopenia during maintenance therapy with prednisolone. Dig Dis Sci 2003; 48 (10) 1968-1971
    CrossrefPubMedGoogle Scholar
  • 134 Umehara H, Okazaki K, Masaki Y , et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22 (1) 21-30
    CrossrefPubMedGoogle Scholar
  • 135 Kawa S, Ota M, Yoshizawa K , et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122 (5) 1264-1269
    CrossrefPubMedGoogle Scholar
  • 136 Freitag TL, Cham C, Sung HH , et al. Human risk allele HLA-DRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis. Gastroenterology 2010; 139 (1) 281-291
    CrossrefPubMedGoogle Scholar
  • 137 Watanabe T, Yamashita K, Fujikawa S , et al. Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors is involved in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum 2012; 64 (3) 914-924
    CrossrefPubMedGoogle Scholar
  • 138 Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?. J Cell Mol Med 2005; 9 (3) 741-744
    CrossrefPubMedGoogle Scholar
  • 139 Frulloni L, Lunardi C, Simone R , et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009; 361 (22) 2135-2142
    CrossrefPubMedGoogle Scholar
  • 140 Rock B, Martins CR, Theofilopoulos AN , et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989; 320 (22) 1463-1469
    CrossrefPubMedGoogle Scholar
  • 141 Beck Jr LH, Bonegio RG, Lambeau G , et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361 (1) 11-21
    CrossrefPubMedGoogle Scholar